XML 22 R6.htm IDEA: XBRL DOCUMENT v3.26.1
CONSOLIDATED STATEMENT OF CASH FLOWS - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Cash flows from operating activities:      
Net loss $ (55,807) $ (111,754) $ (114,208)
Adjustments to reconcile net loss to net cash used in operating activities:      
Depreciation 3,090 3,182 2,255
Accretion income on short-term investments 0 0 (731)
Share-based compensation 5,067 9,585 16,278
Change in fair value of warrants liability (37,953) 22,750 (396)
Change in fair value of derivative liability (11,751) 9,143 (240)
Amortization of discount of convertible promissory note 883 476 30
Interest expenses 932 872 81
Decrease (increase) in accrued interest on short-term investments 0 895 (169)
Decrease (increase) in inventory 3,075 (3,412) (463)
Decrease (increase) in accounts receivable (13) 444 (455)
Decrease (increase) in other accounts receivable and prepaid expenses 5,269 (419) 5,401
Change in operating lease right-of-use assets and liabilities, net 1,065 390 2,123
Increase (decrease) in trade payables (4,280) 1,905 (901)
Increase (decrease) in other accounts payable and accrued expenses (1,230) (4,956) 2,928
Increase (decrease) in deferred tax liability (1,782) 1,782 0
Decrease in deferred revenue 0 0 (943)
Impairment of long-lived assets 24,716 0 0
Loss from property and equipment sales and disposals 9 132 137
Net cash used in operating activities (68,710) (68,985) (89,273)
Cash flows from investing activities:      
Purchase of property and equipment (6,305) (7,531) (3,745)
Proceeds from sale of property and equipment 100 0 0
Purchases of short-term investments 0 0 (94,364)
Proceeds from short-term investments 0 43,500 147,726
Net cash provided by (used in) investing activities (6,205) 35,969 49,617
Cash flows from financing activities:      
Proceeds from issuance of Ordinary Shares, net 34,361 45,535 467
Proceeds from exercise of options and warrants 1 13 129
Repayment of short term loan (18,000) (15,000) 0
Proceeds from short term loan 0 18,000 15,000
Proceeds from issuance of warrants 0 15,000 3,633
Proceeds from bifurcated embedded derivatives 0 0 4,179
Proceeds from convertible note 0 0 563
Net cash provided by financing activities 16,362 63,548 23,971
Increase (Decrease) in cash, cash equivalents and restricted cash (58,553) 30,532 (15,685)
Cash, cash equivalents and restricted cash at beginning of year 74,772 44,240 59,925
Cash, cash equivalents and restricted cash at end of period 16,219 74,772 44,240
Non-cash activity:      
Purchase of property and equipment in trade payables and other accounts payable and accrued expenses 1,063 48 54
Conversion of convertible notes 0 550 0
Derecognition of ROU assets and lease liabilities due to lease reassessment 1,023 0 0
Share settlement of employee liability 0 1,124 0
Right-of-use assets obtained in exchange for lease liabilities 343 2,230 1,097
Transfer from inventory to property and equipment, net 0 800 0
Prepaid purchases classified as property and equipment 1,903 0 0
Supplemental disclosure of cash flows information:      
Cash paid for income taxes 79 358 995
Interest paid 27 51 0
Reconciliation of cash, cash equivalents and restricted cash:      
Cash and cash equivalents 14,246 72,262 41,232
Non-current restricted cash 1,973 2,510 3,008
Total cash, cash equivalents and restricted cash $ 16,219 $ 74,772 $ 44,240